Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Embla Medical

30.60 DKK

+0.99 %

Less than 1K followers

EMBLA

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
+0.99 %
-4.97 %
-5.85 %
-11.30 %
+0.33 %
-10.00 %
-10.66 %
-31.85 %
+456.36 %

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more
Market cap
13.17B DKK
Turnover
345.62K DKK
Revenue
5.91B
EBIT %
13.49 %
P/E
24.55
Dividend yield-%
-
Coverage
Disclaimer
Michael Friis
Michael Friis

Head of Equities

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.3
2026

General meeting '26

28.4
2026

Interim report Q1'26

21.7
2026

Interim report Q2'26

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release2/9/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Embla Medical: Recording of FY 2025 results presentation
Analyst Comment2/3/2026, 1:59 PM by
Michael Friis

Embla Medical: Recording of FY 2025 results presentation

Today, Embla Medical’s CEO, Sveinn Sölvason, presented the FY 2025 results and outlined the key drivers behind the expectations for 2026. These expectations underline a stable structural growth case and are well aligned with the company’s mid-term 2027 targets.

Embla Medical
Embla Medical – Presentation of the Annual Report 2025
Webcast2/3/2026, 9:30 AM

Embla Medical – Presentation of the Annual Report 2025

Embla Medical will publish its Annual Report for 2025 on 3 February 2026. At 10:30 CET, CEO Sveinn Sölvason will present the results, comment on the most important developments in the business, and provide the company’s outlook for 2026, followed by a live online Q&A session.

Embla Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
HCA Morgenbørs 03/02 - Regnskabssæsonen bliver skudt i gang i Danmark
Video2/3/2026, 8:16 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 03/02 - Regnskabssæsonen bliver skudt i gang i Danmark

I dagens Morgenbørs ser vi ind i en positiv start på dagen i Europa, vores kald om at aktier kunne modstå volatilitet i råvarer holdt. Herhjemme fokus Demant, Netcompany, Embla, Novo Nordisk og Ørsted.

ISSNovo NordiskØrstedDemantNetcompany GroupGN Store NordEmbla MedicalRTXBavarian NordicPandoraTormNorth Media
Dagens aktienyheder 03/02-2026: ISS og Embla
Analyst Comment2/3/2026, 7:50 AM by
Victor Skriver

Dagens aktienyheder 03/02-2026: ISS og Embla

Dagens aktienyheder 03/02-2026: ISS og Embla

ISSEmbla Medical
Mød ledelsen i RTX og Embla Medical og stil spørgsmål i dagens investorpræsentationer
Analyst Comment2/3/2026, 7:30 AM by
Philip Coombes

Mød ledelsen i RTX og Embla Medical og stil spørgsmål i dagens investorpræsentationer

Mød ledelsen i RTX og Embla Medical og stil spørgsmål i dagens investorpræsentationer

RTXEmbla Medical
Regulatory press release2/3/2026, 6:05 AM

Embla Medical hf.: Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum

Embla Medical
Regulatory press release2/3/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Interim Report Q4 and Full Year 2025

Embla Medical
Regulatory press release2/2/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/26/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/19/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/12/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Press release1/9/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Conference call details for Q4/FY 2025

Embla Medical
Regulatory press release12/23/2025, 4:30 PM

Embla Medical hf.: Embla Medical hf: Initiating New Share Buyback Program

Embla Medical
Regulatory press release12/23/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Share Buyback Program Completed

Embla Medical
Regulatory press release12/22/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release12/15/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release12/12/2025, 4:00 PM

Embla Medical hf.: Embla Medical: Financial Calendar 2026

Embla Medical
Regulatory press release12/8/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release12/1/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.